Papilledema and obstructive sleep apnea syndrome.

Détails

ID Serval
serval:BIB_3550EEACBC02
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Papilledema and obstructive sleep apnea syndrome.
Périodique
Archives of ophthalmology
Auteur⸱e⸱s
Purvin V.A., Kawasaki A., Yee R.D.
ISSN
0003-9950
Statut éditorial
Publié
Date de publication
2000
Peer-reviewed
Oui
Volume
118
Numéro
12
Pages
1626-30
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
OBJECTIVES: To characterize the pathogenesis and clinical features of optic disc edema associated with obstructive sleep apnea syndrome (SAS). METHODS: A series of 4 patients with SAS and papilledema (PE) underwent complete neuro-ophthalmologic evaluation and lumbar puncture. In 1 patient, continuous 24-hour intracranial pressure (ICP) monitoring was also performed. RESULTS: All 4 patients had bilateral PE that was asymmetric in 2. Three patients had optic nerve dysfunction, asymmetric in 1, unilateral in 2. Daytime cerebrospinal fluid pressure measurements were within normal range. Nocturnal monitoring performed in one patient, however, demonstrated repeated episodes of marked ICP elevation associated with apnea and arterial oxygen desaturation. CONCLUSIONS: We propose that PE in SAS is due to episodic nocturnal hypoxemia and hypercarbia resulting in increased ICP secondary to cerebral vasodilation. In these individuals, intermittent ICP elevation is sufficient to cause persistent disc edema. These patients may be at increased risk for developing visual loss secondary to PE compared with patients with obesity-related pseudotumor cerebri because of associated hypoxemia. The diagnosis of SAS PE may not be appreciated because daytime cerebrospinal fluid pressure measurements are normal and because patients tend to present with visual loss rather than with symptoms of increased ICP.
Mots-clé
Acetazolamide/therapeutic use, Adult, Carbonic Anhydrase Inhibitors/therapeutic use, Cerebrospinal Fluid Pressure, Fundus Oculi, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Papilledema/complications, Papilledema/diagnosis, Perimetry, Sleep Apnea, Obstructive/complications, Sleep Apnea, Obstructive/diagnosis, Tomography, X-Ray Computed, Tracheostomy, Visual Acuity, Visual Fields
Pubmed
Web of science
Création de la notice
23/11/2009 19:02
Dernière modification de la notice
20/08/2019 14:22
Données d'usage